BIOMAT Database Logo BIOMAT Database Logo

Plasmapheresis and myasthenia gravis. 1978

P Jacobs, and D Dubovsky, and A Ferguson

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

P Jacobs, and D Dubovsky, and A Ferguson
[Plasmapheresis in myasthenia gravis].
January 1981, Medicina,
P Jacobs, and D Dubovsky, and A Ferguson
Plasmapheresis in myasthenia gravis.
January 1987, Annals of the New York Academy of Sciences,
P Jacobs, and D Dubovsky, and A Ferguson
[Plasmapheresis for myasthenia gravis].
February 1978, The New England journal of medicine,
P Jacobs, and D Dubovsky, and A Ferguson
Plasmapheresis in myasthenia gravis.
January 1982, Progress in clinical and biological research,
P Jacobs, and D Dubovsky, and A Ferguson
[Plasmapheresis in myasthenia gravis].
March 1986, Medicina clinica,
P Jacobs, and D Dubovsky, and A Ferguson
Plasmapheresis for myasthenia gravis.
July 1979, The Medical letter on drugs and therapeutics,
P Jacobs, and D Dubovsky, and A Ferguson
Plasmapheresis in myasthenia gravis.
October 1981, Annals of neurology,
P Jacobs, and D Dubovsky, and A Ferguson
[Plasmapheresis therapy of myasthenia gravis].
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
P Jacobs, and D Dubovsky, and A Ferguson
Plasmapheresis therapy in myasthenia gravis.
January 1980, Muscle & nerve,
P Jacobs, and D Dubovsky, and A Ferguson
[Myasthenia gravis treated with plasmapheresis].
December 1989, Casopis lekaru ceskych,
Copied contents to your clipboard!